CNS & Neurological Disorders - Drug Targets

1.7k papers and 39.7k indexed citations i.

About

The 1.7k papers published in CNS & Neurological Disorders - Drug Targets in the last decades have received a total of 39.7k indexed citations. Papers published in CNS & Neurological Disorders - Drug Targets usually cover Molecular Biology (541 papers), Cellular and Molecular Neuroscience (347 papers) and Physiology (316 papers) specifically the topics of Alzheimer's disease research and treatments (168 papers), Cholinesterase and Neurodegenerative Diseases (129 papers) and Tryptophan and brain disorders (127 papers). The most active scholars publishing in CNS & Neurological Disorders - Drug Targets are Stephen D. Skaper, Mohammad Amjad Kamal, José Javier Miguel-Hidalgo, Grażyna Rajkowska, Donna M. Wilcock, Carol A. Colton, Óscar Arias-Carrión, Nigel H. Greig, Antonio Armario and Josée Guindon.

In The Last Decade

Fields of papers published in CNS & Neurological Disorders - Drug Targets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in CNS & Neurological Disorders - Drug Targets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in CNS & Neurological Disorders - Drug Targets.

Countries where authors publish in CNS & Neurological Disorders - Drug Targets

Since Specialization
Citations

This map shows the geographic impact of research published in CNS & Neurological Disorders - Drug Targets. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in CNS & Neurological Disorders - Drug Targets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CNS & Neurological Disorders - Drug Targets more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025